Word

BIPHASIX

Status

Dead

Status Code

606

Status Date

Saturday, November 22, 2003

Serial Number

75546684

Mark Type

1000

Filing Date

Wednesday, September 2, 1998

Published for Opposition

Tuesday, August 29, 2000

Abandoned Date

Saturday, November 22, 2003

Trademark Owner History

PHARMADERM LABORATORIES LTD. - Owner At Publication

Classifications

5 DERMAL AND MUCOSAL DRUG DELIVERY SYSTEMS COMPRISED OF LIQUIDS, CREAMS AND GELS APPLIED TO THE SKIN OR MUCOSA AND CONTAINING PHARMACEUTICAL AGENTS ENCAPSULATED IN VESICLES UTILIZING A LIPID-BASED MICROENCAPSULATING PROCESS, FOR USE IN THE TREATMENT OF CARDIOLOGICAL DISEASES, DERMATOLOGICAL DISEASES, ENDOCRINE DISORDERS, GASTROINTESTINAL DISORDERS, HEMATOLOGICAL DISORDERS, BACTERIAL INFECTIOUS DISEASES, FUNGAL INFECTIOUS DISEASES, PARASITIC INFECTIOUS DISEASES, VIRAL INFECTIOUS DISEASES, MALIGNANT CANCER DISORDERS, METABOLIC DISEASES, NEUROLOGICAL DISORDERS, OPHTHALMOLOGY, DISORDERS, POISONING DISORDERS PSYCHIATRIC DISORDERS, PULMONARY DISORDERS, RENAL DISORDERS, RHEUMATOLOGICAL DISORDERS, NAUSEA, DIARRHEA, LOCAL PAIN, SYSTEMIC PAIN, OBESITY, ERECTILE DYSFUNCTION, SARCOIDOSIS, SLEEP DISORDERS AND PROVIDING VACCINE TREATMENTS

Trademark Events

Dec 30, 2003

Abandonment - No Use Statement Filed

Jun 17, 2003

Extension 5 Granted

May 21, 2003

Extension 5 Filed

May 21, 2003

Paper Received

Jan 23, 2003

Extension 4 Granted

Nov 13, 2002

Extension 4 Filed

Nov 15, 2002

Paper Received

May 22, 2002

Extension 3 Granted

May 10, 2002

Extension 3 Filed

May 13, 2002

Paper Received

Dec 10, 2001

Extension 2 Granted

Nov 20, 2001

Extension 2 Filed

May 24, 2001

Extension 1 Granted

May 11, 2001

Extension 1 Filed

Nov 21, 2000

Noa Mailed - Sou Required From Applicant

Aug 29, 2000

Published For Opposition

Jul 28, 2000

Notice Of Publication

Apr 21, 2000

Approved For Pub - Principal Register

Feb 14, 2000

Correspondence Received In Law Office

Oct 20, 1999

Final Refusal Mailed

Aug 16, 1999

Correspondence Received In Law Office

Apr 30, 1999

Non-Final Action Mailed

Apr 13, 1999

Assigned To Examiner